Daniel Truong Selected Research

Torticollis (Wryneck)

1/2022	Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study.
1/2021	AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions.
1/2019	Cervical dystonia: Injecting botulinum neurotoxin into semispinalis capitis improves goose-neck posture.
5/2018	Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study.
5/2017	Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry.
9/2016	Poster 296 AbobotulinumtoxinA Injection Patterns in Patients with Cervical Dystonia from the ANCHOR-CD Registry Study.
8/2015	Collum-caput (COL-CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shift.
11/2014	IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated.
6/2013	Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
2/2013	AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Truong Research Topics

Disease

12	Torticollis (Wryneck) 01/2022 - 07/2005
8	Parkinson Disease (Parkinson's Disease) 10/2021 - 07/2008
4	Blepharospasm 08/2016 - 01/2008
2	Dementia (Dementias) 10/2021 - 04/2019
2	Movement Disorders (Movement Disorder) 01/2018 - 06/2013
2	Deglutition Disorders (Dysphagia) 05/2017 - 02/2013
2	Dystonic Disorders (Writer's Cramp) 06/2013 - 05/2012
2	Neoplasms (Cancer) 01/2012 - 12/2011
1	Frontotemporal Dementia (Semantic Dementia) 10/2021
1	Alzheimer Disease (Alzheimer's Disease) 10/2021
1	Cognitive Dysfunction 10/2021
1	Neuroinflammatory Diseases 12/2020
1	Hallucinations (Hallucination) 04/2019
1	Tardive Dyskinesia 01/2018
1	Multiple System Atrophy 11/2017
1	Muscle Weakness 05/2017
1	Neck Pain (Cervicalgia) 05/2017
1	Disease Progression 04/2017
1	Dyskinesias (Dyskinesia) 05/2015
1	Parkinsonian Disorders (Parkinsonism) 03/2014
1	Hyperhidrosis 06/2013
1	Autonomic Nervous System Diseases (Dysautonomia) 06/2013
1	Sialorrhea 06/2013
1	Rhinorrhea 06/2013
1	Hemifacial Spasm 06/2013
1	Tics (Tic) 06/2013
1	Essential Tremor (Essential Tremors) 06/2013
1	Dystonia (Limb Dystonia) 06/2013
1	Squamous Cell Carcinoma of Head and Neck 01/2012
1	Hypoxia (Hypoxemia) 01/2012
1	Pain (Aches) 06/2010
1	Benign essential blepharospasm 01/2008
1	Spasm (Spasms) 01/2008

Drug/Important Bio-Agent (IBA)

7	Botulinum Toxins (Botulinum Toxin)IBA 01/2022 - 01/2008
7	abobotulinumtoxinA FDA Link 01/2021 - 07/2005
5	incobotulinumtoxinA FDA Link 01/2022 - 06/2013
5	Type A Botulinum Toxins (Botox)FDA Link 08/2016 - 07/2005
3	Caffeine (No Doz)FDA LinkGeneric 04/2017 - 07/2008
2	NeurotoxinsIBA 12/2020 - 05/2017
2	CreatineIBA 04/2017 - 09/2015
1	Polytetrafluoroethylene (Teflon)FDA Link 10/2021
1	propylene diquat (PDQ(+))IBA 01/2021
1	Sirtuin 1IBA 12/2020
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 04/2019
1	Dopamine Agents (Dopaminergic Agents)IBA 04/2019
1	rotigotine FDA Link 01/2019
1	deutetrabenazineIBA 01/2018
1	valbenazineIBA 01/2018
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 11/2017
1	Pharmaceutical PreparationsIBA 05/2017
1	Amantadine (Aman)FDA LinkGeneric 05/2015
1	Levodopa (L Dopa)FDA LinkGeneric 05/2015
1	Neutralizing AntibodiesIBA 11/2014
1	ioflupaneIBA 03/2014
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 03/2014
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2012
1	Cytotoxins (Cytolysins)IBA 01/2012
1	Tirapazamine (SR 4233)IBA 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	OsteopontinIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 12/2011

Therapy/Procedure

5	Therapeutics 01/2022 - 07/2008
5	Injections 05/2018 - 02/2013
1	Wearable Electronic Devices 01/2019
1	Radiotherapy 01/2012
1	Activities of Daily Living (ADL) 07/2008